Clinical trials are organized studies that are designed to determine the safety and effectiveness of a new treatment. The most promising agents and therapies are selected for inclusion in the treatment studies at the Methodist Neuroscience Institute.
For current Clinical Trials, please contact:
Rexann G. Pickering, Ph.D., R.N.
Administrator, Human Protection
MHIRB Administration
1325 Eastmoreland Ave., Suite 574
Memphis, Tennessee 38104
Phone: 901.516.2323
Fax: 901.516-2456
|
To view this site, you need to have Flash Player 9.0 or later
installed. Click here to get the latest Flash player.
|
|
2007-040 |
| A Phase II Study of Gliadel®, Concomitant Temozolomide and Radiation, Followed by Metronomic Therapy with Temozolomide for Newly Diagnosed High Grade Glioma |
2007-050 |
| A Phase II, Multicenter, Exploratory Study, Evaluating the Treatment Effect of Surgery Plus Gliadel Wafer in Patients with Metastatic Brain Cancer |
|
|
|
